Skip to content
Pics_all-03
Pics_all
Pics_all-07
jd-mason-cKT0oJL9vMI-unsplash_2

Who We Are

We are academics with commercial savvy. Innovative problem-solvers driven by curiosity and compassion. Strategic communicators. Skilled project managers.

We go beyond the page to ensure clients receive comprehensive patient insights and compelling action plans, and execute programmes with excellence.

We publish in peer-review journals, present original research at industry and scientific conferences. We speak with FDA and EMA – and anticipate what regulators expect to see.

Most importantly, we are champions of the patient perspective.

Our Amazing Team

Our clients have direct and consistent access to senior, skilled experts.

PhD, Sociology  |  Lead Scientist

Medical sociologist with research and consulting expertise in patient-centred outcomes, shared decision-making and qualitative research methods.

BSc  | Head of Operations

Senior project manager specialising in pharma, wellness, patient support and behaviour change projects.

Project Manager

Project manager with background in executive administration and management support in the healthcare and banking industries.

PhD  |  Partner

Health psychologist with research and consulting expertise in patient-centred outcomes and treatment adherence.

PhD, CPsychol  |  Principal

Psychologist specialised in understanding patients’ perceptions and experiences of illness, treatment and healthcare services, and developing interventions to address unmet need.

Office Manager

Office Manager with 13 years of experience in maintaining administrative systems, bookkeeping and ISO management.

PhD, CPsychol  |  Partner

Specialised in understanding, measuring and improving treatment adherence and other behaviours that impact health. Experienced in identification and validation of clinical outcomes assessments for use in clinical trials and in-patient preference studies.

MPH | Scientist

Qualitative scientist with experience in patient-reported outcomes, qualitative research methodology and digital health interventions.

PhD, CPsychol  |  Senior Scientist

Health psychologist with expertise in symptom experience and adjustment to long-term conditions. Special focus on supporting patients with persistent physical symptoms, specifically fatigue.

PhD, CPsychol  |  Partner

Behavioural psychologist specialising in improving adherence to medication for long-term conditions, and changing healthcare professional (HCP) behaviour to improve services.

PhD, CPsychol  | Lead Scientist

Health Psychologist specialising in public health and improving patient adherence to treatment recommendations, including adherence to non-pharmacological treatments.

MSEd  |  Scientist

Qualitative scientist with research and consulting expertise in patient-centred outcomes and qualitative research methods

PhD | Senior Scientist

10 years of experience in health research. Worked in academic and commercial settings with healthcare professionals, patients, and caregivers.

MA | Senior Principal

Qualitative researcher with expertise in patient-centered outcomes and a focus in pediatrics and rare disease.

BA, ACMA / Finance Director (Headline FD)

Seasoned finance professional with over 30 years’ international experience in senior positions across a wide range of sectors.

BSc (Hons) | Project Manager

Extensive background in client services and support, including the coordination of clinical trials and dealing with regulatory bodies.

BCom  |  Senior Project Manager

Specialised in setting up and delivering pharma-led projects, behaviour change initiatives and patient support programmes.

The Sprout Story

Women-founded/owned

Christina Jackson and Lina Eliasson established Sprout in 2017 to elevate the role of behaviour science in pharma-sponsored programmes that support patients living with chronic health conditions. Their vision was for industry-seasoned psychologists to lead all projects, applying academic skills and evidence-based theories to understand the patient experience, improve engagement and change unhealthy behaviours. It was bold thinking at the time, and now regarded as a pioneering move within the industry.

In 2019, Sarah Clifford joined and launched Sprout’s Clinical Outcome Assessment (COA) division. It’s a synergistic service line that expands Sprout’s unique ability to engage patients so their voices guide every stage of drug development, from pre-Phase 1 through commercialisation and the real world.

Today, Sprout has a robust scientific team of health psychology and medical sociology PhDs and project managers serving pharma and biotech clients worldwide across disease states.

What’s Behind the Name?

The Sprout name honours the positive forces of transformation and growth.

  • 2017

    Sprout Behaviour Change founded in U.K.

  • 2019

    Sprout U.S. office established

  • 2019

    Launch of Sprout’s COA division

  • 2020

    Digital Therapeutics (DTx) launched, including Software as Medical Device (SaMD) capabilities

  • 2021

    Company rebranded as Sprout Health Solutions

Our Strategic Partners